Professor | Weichun Guo | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Weichun Guo
Contact Information	guoweichun@aliyun.com
Language ability	Chinese, English
Province	Hubei

Upload Avatar (500 x 500)

Name

Weichun Guo

Contact Information

guoweichun@aliyun.com

Language ability

Chinese, English

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	1988-1994: Bachelor's Degree in Clinical Medicine from Hubei University of Science and Technology 1997-2000: Master's Degree from Tongji Medical College, Huazhong University of Science and Technology 2005-2008: PhD from Tongji Medical College, Huazhong University of Science and Technology Has led multiple research projects and received provincial awards
Work Experience	2004-2007: Attending Physician, Department of Spine Surgery, Renmin Hospital, Wuhan University 2007-2013: Deputy Chief Physician, Department of Spine Surgery, Renmin Hospital, Wuhan University 2008-Present: Associate Professor, Department of Spine Surgery, Renmin Hospital, Wuhan University 2013-Present: Chief Physician, Department of Spine Surgery, Renmin Hospital, Wuhan University
Awards	2007: Third Prize of Natural Science of Hubei Province 2021: Second Prize of Hubei Science and Technology Progress Award (Principal Investigator)

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

1988-1994: Bachelor's Degree in Clinical Medicine from Hubei University of Science and Technology
1997-2000: Master's Degree from Tongji Medical College, Huazhong University of Science and Technology
2005-2008: PhD from Tongji Medical College, Huazhong University of Science and Technology
Has led multiple research projects and received provincial awards

Work Experience

2004-2007: Attending Physician, Department of Spine Surgery, Renmin Hospital, Wuhan University
2007-2013: Deputy Chief Physician, Department of Spine Surgery, Renmin Hospital, Wuhan University
2008-Present: Associate Professor, Department of Spine Surgery, Renmin Hospital, Wuhan University
2013-Present: Chief Physician, Department of Spine Surgery, Renmin Hospital, Wuhan University

Awards

2007: Third Prize of Natural Science of Hubei Province
2021: Second Prize of Hubei Science and Technology Progress Award (Principal Investigator)

Areas of Focus	Spinal surgery and bone tumors Biomaterials for bone regeneration
Publications	TRIM26 inhibited osteosarcoma progression through destabilizing RACK1 and thus inactivation of MEK/ERK signaling, Xia KZ, Zheng D, Wei Z, Guo WC, 2023 Carboxymethyl chitosan-alginate enhances bone repair effects of magnesium phosphate bone cement by activating the FAK-Wnt pathway, Yu L, Gao T, Li W, Yang J, Liu Y, Zhao Y, He P, Li X, Guo W, Fan Z, Dai H, 2022 Identification of a Solute Carrier Family-Based Signature for Predicting Overall Survival in Osteosarcoma, Zheng D, Wei Z, Guo W, 2022 N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma, Zheng D, Yu L, Wei Z, Xia K, Guo W, 2022 Comprehensive Analysis of a Zinc Finger Protein Gene-Based Signature with Regard to Prognosis and Tumor Immune Microenvironment in Osteosarcoma, Sun X, Zheng D, Guo W, 2022 A Novel Six Metastasis-Related Prognostic Gene Signature for Patients With Osteosarcoma, Zheng D, Xia K, Yu L, Gong C, Shi Y, Li W, Qiu Y, Yang J, Guo W, 2021 Enhancing the mechanical properties and cytocompatibility of magnesium potassium phosphate cement by incorporating oxygen-carboxymethyl chitosan, Gong C, Fang S, Xia K, Chen J, Guo L, Guo W, 2020 FBXO2 modulates STAT3 signaling to regulate proliferation and tumorigenicity of osteosarcoma cells, Zhao X, Guo W, Zou L, Hu B, 2020 LncRNA PLAC 2 Is Downregulated in Osteosarcoma and Regulates Cancer Cell Proliferation Through miR-93, Sun X, Yu L, Shi Y, Guo W, 2020 An injectable bioactive magnesium phosphate cement incorporating carboxymethyl chitosan for bone regeneration, Yu L, Xia K, Gong C, Chen J, Li W, Zhao Y, Guo W, Dai H, 2020 CDKN2B-AS1 Exerts Oncogenic Role in Osteosarcoma by Promoting Cell Proliferation and Epithelial to Mesenchymal Transition, Luo Y, Tao H, Jin L, Xiang W, Guo W, 2020 Proscillaridin A induces apoptosis and inhibits the metastasis of osteosarcoma in vitro and in vivo, Fang S, Tao H, Xia K, Guo W, 2020 The Notch Pathway Promotes Osteosarcoma Progression through Activation of Ephrin Reverse Signaling, Yu L, Xia K, Gao T, Chen J, Zhang Z, Sun X, Simões BM, Eyre R, Fan Z, Guo W, Clarke RB, 2019 Synergistic effect of docetaxel combined with cisplatin on inhibiting human osteosarcoma in nude mice, Tao H, Tang X, Jin L, Zhao Y, Luo Y, Zhang Z, Cai L, Tao F, Guo W, 2018 Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma, Dai G, Deng S, Guo W, Yu L, Yang J, Zhou S, Gao T, 2019

Areas of Focus

Spinal surgery and bone tumors
Biomaterials for bone regeneration

Publications

TRIM26 inhibited osteosarcoma progression through destabilizing RACK1 and thus inactivation of MEK/ERK signaling, Xia KZ, Zheng D, Wei Z, Guo WC, 2023
Carboxymethyl chitosan-alginate enhances bone repair effects of magnesium phosphate bone cement by activating the FAK-Wnt pathway, Yu L, Gao T, Li W, Yang J, Liu Y, Zhao Y, He P, Li X, Guo W, Fan Z, Dai H, 2022
Identification of a Solute Carrier Family-Based Signature for Predicting Overall Survival in Osteosarcoma, Zheng D, Wei Z, Guo W, 2022
N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma, Zheng D, Yu L, Wei Z, Xia K, Guo W, 2022
Comprehensive Analysis of a Zinc Finger Protein Gene-Based Signature with Regard to Prognosis and Tumor Immune Microenvironment in Osteosarcoma, Sun X, Zheng D, Guo W, 2022
A Novel Six Metastasis-Related Prognostic Gene Signature for Patients With Osteosarcoma, Zheng D, Xia K, Yu L, Gong C, Shi Y, Li W, Qiu Y, Yang J, Guo W, 2021
Enhancing the mechanical properties and cytocompatibility of magnesium potassium phosphate cement by incorporating oxygen-carboxymethyl chitosan, Gong C, Fang S, Xia K, Chen J, Guo L, Guo W, 2020
FBXO2 modulates STAT3 signaling to regulate proliferation and tumorigenicity of osteosarcoma cells, Zhao X, Guo W, Zou L, Hu B, 2020
LncRNA PLAC 2 Is Downregulated in Osteosarcoma and Regulates Cancer Cell Proliferation Through miR-93, Sun X, Yu L, Shi Y, Guo W, 2020
An injectable bioactive magnesium phosphate cement incorporating carboxymethyl chitosan for bone regeneration, Yu L, Xia K, Gong C, Chen J, Li W, Zhao Y, Guo W, Dai H, 2020
CDKN2B-AS1 Exerts Oncogenic Role in Osteosarcoma by Promoting Cell Proliferation and Epithelial to Mesenchymal Transition, Luo Y, Tao H, Jin L, Xiang W, Guo W, 2020
Proscillaridin A induces apoptosis and inhibits the metastasis of osteosarcoma in vitro and in vivo, Fang S, Tao H, Xia K, Guo W, 2020
The Notch Pathway Promotes Osteosarcoma Progression through Activation of Ephrin Reverse Signaling, Yu L, Xia K, Gao T, Chen J, Zhang Z, Sun X, Simões BM, Eyre R, Fan Z, Guo W, Clarke RB, 2019
Synergistic effect of docetaxel combined with cisplatin on inhibiting human osteosarcoma in nude mice, Tao H, Tang X, Jin L, Zhao Y, Luo Y, Zhang Z, Cai L, Tao F, Guo W, 2018
Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma, Dai G, Deng S, Guo W, Yu L, Yang J, Zhou S, Gao T, 2019

Spinal Surgery Bone Tumors Osteosarcoma Bone Repair Biomaterials Surgical Techniques Cancer Treatment Regenerative Medicine Clinical Research Tissue Engineering

Yue Shi - Southern University of Science and Technology

Lin Wang - Southern University of Science and Technology

Wang Ge - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us